P980053/S021: Durasphere Injectable Bulking Agent
FDA’s recorded scope: a change to the syringe cap of the 1 mL Durasphere device configuration
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Carbon Medical Technologies, Inc.. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 13, 2026 to Mar 31, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FBK appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P980053, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 1290 Hammond Rd., St. Paul, MN, 55110, US. Recorded on K253598, decision dated Mar 31, 2026.
Endoscopic Injection Needle, Gastroenterology-Urology; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE.
FDA’s recorded scope: a change to the syringe cap of the 1 mL Durasphere device configuration
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
InjecSURE Injection SystemK253598 | Carbon Medical Technologies, Inc. | 510(k) clearance | Mar 31, 2026 | FDA |
Durasphere Injectable Bulking AgentP980053/S021 | Carbon Medical Technologies, Inc. | PMA supplement | Mar 13, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.